Correlation Between ExpreS2ion Biotech and Combigene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ExpreS2ion Biotech and Combigene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ExpreS2ion Biotech and Combigene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ExpreS2ion Biotech Holding and Combigene AB, you can compare the effects of market volatilities on ExpreS2ion Biotech and Combigene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ExpreS2ion Biotech with a short position of Combigene. Check out your portfolio center. Please also check ongoing floating volatility patterns of ExpreS2ion Biotech and Combigene.

Diversification Opportunities for ExpreS2ion Biotech and Combigene

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between ExpreS2ion and Combigene is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding ExpreS2ion Biotech Holding and Combigene AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Combigene AB and ExpreS2ion Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ExpreS2ion Biotech Holding are associated (or correlated) with Combigene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Combigene AB has no effect on the direction of ExpreS2ion Biotech i.e., ExpreS2ion Biotech and Combigene go up and down completely randomly.

Pair Corralation between ExpreS2ion Biotech and Combigene

Assuming the 90 days trading horizon ExpreS2ion Biotech Holding is expected to generate 2.44 times more return on investment than Combigene. However, ExpreS2ion Biotech is 2.44 times more volatile than Combigene AB. It trades about 0.09 of its potential returns per unit of risk. Combigene AB is currently generating about 0.02 per unit of risk. If you would invest  1,940  in ExpreS2ion Biotech Holding on April 22, 2025 and sell it today you would earn a total of  555.00  from holding ExpreS2ion Biotech Holding or generate 28.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ExpreS2ion Biotech Holding  vs.  Combigene AB

 Performance 
       Timeline  
ExpreS2ion Biotech 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ExpreS2ion Biotech Holding are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, ExpreS2ion Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.
Combigene AB 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Combigene AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Combigene is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

ExpreS2ion Biotech and Combigene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ExpreS2ion Biotech and Combigene

The main advantage of trading using opposite ExpreS2ion Biotech and Combigene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ExpreS2ion Biotech position performs unexpectedly, Combigene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Combigene will offset losses from the drop in Combigene's long position.
The idea behind ExpreS2ion Biotech Holding and Combigene AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios